Litigation Details for In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation (S.D.N.Y. 2017)
✉ Email this page to a colleague
In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation (S.D.N.Y. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-02-07 |
Court | District Court, S.D. New York | Date Terminated | 2023-07-07 |
Cause | 15:78m(a) Securities Exchange Act | Assigned To | Ronnie Abrams |
Jury Demand | Plaintiff | Referred To | Barbara Moses |
Parties | SERGEY REGUKH | ||
Patents | 10,154,681; 7,737,112 | ||
Attorneys | Rebecca Matsumura | ||
Firms | King & Spalding LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation
Biologic Drugs cited in In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation
Details for In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation (S.D.N.Y. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-06-12 | 188 | Exhibit 3- FXCM Form S-1 dated 12/1/10 | 4 (8,761,570) (10,154,681) Exceptional items … (8,761,570) (10,154,681) Depreciation (note 8) … do not have any pending or issued patents. We use the following service… we have applied for registration with the U.S. Patent and Trademark Office: Forex Capital | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |